Skip to main content

Bank of New York Mellon Corp

Bank

Position in TRVI — Trevi Therapeutics, Inc.

CIK 1390777 NEW YORK, NY

Position in TRVI

as of Mar 31, 2026 · filed May 5, 2026
Position Value
$3,103,719
-$158,828 QoQ
Shares Held
260,161
-0.2% QoQ
Ownership
0.183%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2022
15 quarters on record
Voting authority Sole 84.03796110869808.ToString("F0")% Shared 0.ToString("F0")% None 15.962038891301924.ToString("F0")%

Common Shares in TRVI Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Bank of New York Mellon Corp holds $4,203,649,111 across 269 Biotechnology names. TRVI ranks #109 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in TRVI

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $3,103,719 260,161
2025-12-31 $3,262,547 260,587
2025-09-30 $2,071,000 226,339
2025-06-30 $909,467 166,265
2025-03-31 $1,044,617 166,076
2024-12-31 $577,701 140,219
2024-09-30 $458,527 137,284
2024-06-30 $531,962 178,511
2024-03-31 $443,762 128,627
2023-12-31 $178,729 133,381
2023-09-30 $292,294 134,080
2023-06-30 $315,161 131,867
2023-03-31 $26,081 14,098
2022-12-31 $27,209 14,098
2022-09-30 $21,710 14,098